DigestRedComo funciona
Red
/
Empresas
Sa
No verificado

Satellos BioScience Inc.

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaMedicina - VariosSalud

45 Comunicados de prensa

Ver todos los comunicados de prensa
09/12/2025
Material médico sanitario
Higiene alimentaria
Salud
Medicina - Varios
Biotecnología
Satellos Receives Clearance by U.S. FDA and Global Regulators to Initiate Pediatric Phase 2 Study of SAT-3247 for Duchenne Muscular Dystrophy
Fuente
Satellos BioScience Inc.
Editor
Business Wire
1.00
0
25/11/2025
Web y redes sociales
Eventos
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Satellos to Participate in December Investor Conferences
Fuente
Satellos BioScience Inc.
Editor
Business Wire
1.00
0
18/11/2025
Industria
Salud
Biología
Ciencia
Farmacéutica
Biotecnología
Satellos Announces Publication in Nature Communications Supporting its Novel Treatment Approach for Duchenne Muscular Dystrophy
Fuente
Satellos BioScience Inc.
Editor
Business Wire
1.00
0
14/11/2025
Mercado laboral
Mercado de valores
Salud
Biología
Biotecnología
Medicina - Varios
Farmacéutica
Satellos Reports Third Quarter 2025 Results and Announces Appointment of Mark Nawacki to Board of Directors
Fuente
Satellos BioScience Inc.
Editor
Business Wire
1.00
0
30/10/2025
Biotecnología
Sanidad
Salud
Farmacéutica
Medicina - Varios
Eventos
Satellos to Participate in November Investor Conferences
Fuente
Satellos BioScience Inc.
Editor
Business Wire
1.00
0
21/10/2025
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Industria
Satellos Announces First Adult Patient Dosed in LT-001, an Open-Label, Long-Term Follow-Up Study of SAT-3247 in Duchenne Muscular Dystrophy
Fuente
Satellos BioScience Inc.
Editor
Business Wire
1.00
0
10/10/2025
Salud
Sanidad
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Industria
Satellos Announces New Data Further Demonstrating Safety, Tolerability, and Functional Impact of SAT-3247 in First-in-Human Trial of Adults with Duchenne Muscular Dystrophy
Fuente
Satellos BioScience Inc.
Editor
Business Wire
1.00
0
29/09/2025
Eventos
Industria
Ciencia
Higiene alimentaria
Medicina - Varios
Biología
Biotecnología
Salud
Farmacéutica
Satellos to Present SAT-3247 Phase 1 Clinical Data in Late-Breaking Poster Session at the 2025 World Muscle Society Congress
Fuente
Satellos BioScience Inc.
Editor
Business Wire
1.00
0
22/09/2025
Industria
Ciencia
Biología
Biotecnología
Farmacéutica
Salud
Higiene alimentaria
Medicina - Varios
Satellos Announces IND Submission to the U.S. FDA and Global Regulatory Filings to Advance a Phase 2 Clinical Trial of SAT-3247 in Children with Duchenne Muscular Dystrophy
Fuente
Satellos BioScience Inc.
Editor
Business Wire
1.00
0
21/08/2025
Web y redes sociales
Eventos
Finanzas
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Satellos to Participate in Four September Institutional and Retail Investor Conferences
Fuente
Satellos BioScience Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0